Kim A Reiss (Reiss Binder), MD

faculty photo
Assistant Professor of Medicine at the Hospital of the University of Pennsylvania
Department: Medicine

Contact information
Division of Hematology Oncology
Perelman Center for Advanced Medicine
10th Floor, South Pavilion
Office #10-305
3400 Civic Center Blvd
Philadelphia, PA 19104
Office: 215-360-0735
Fax: 215-662-4646
BA (Psychology)
Colby College, 2002.
Post BA (Pre-Med)
Johns Hopkins University , 2003.
MD (Medicine)
Penn State College of Medicine , 2008.
Permanent link
> Perelman School of Medicine   > Faculty   > Details

Selected Publications

Thatcher R.Heumann, Marina Baretti1, Elizabeth A. Sugar, Jennifer Durham, Sheila Linden, Tearra Miles, Tamara Y Lopez-Vidal, James Leatherman, Nita Ahuja, Anup Sharma, Colin D. Weekes, Peter J. O’Dwyer, Kim Reiss Binder, Dulabh K. Monga, Nilofer S. Azad : Oral Azacitidine (CC-486) in Patients with Resected Pancreatic Adenocarcinoma at High Risk for Recurrence ESMO Annual Meeting, Virtual (COVID) Sept 2021.

Kim A. Reiss, Debora Barton, Amy Ronczka, Daniel Cushing, Michael Klichinsky, Elizabeth Claire Dees : A Phase 1, First in Human Study of Adenovirally Transduced Autologous Macrophages Engineered to Contain an Anti-HER2 Chimeric Antigen Receptor (CAR) in Subjects with HER2 Overexpressing Solid Tumors ESMO Annual Meeting, Virtual (COVID) Sept 2021.

Jada G. Hamilton, PhD, MPH; Heather Symecko, MPH; Kelsey Spielman, MS, CGC; Kelsey Breen, MS, MSc, CGC; Rebecca Mueller, MS, CGC; Amanda Catchings, MS, CGC; Magan Trottier, MSc, MSc, CGC; Erin E. Salo-Mullen, MS, MPH, CGC; Ibrahim Shah, BA; Anna Arutyunova, BS; Melissa Batson, MPH; Rebecca Gebert, BA; Stacy Pundock, BA; Elizabeth Schofield, MPH 1 Kenneth Offit, MD, MPH; Zsofia K. Stadler, MD; Karen Cadoo, MD; Maria I. Carlo, MD; Vivek Narayan, MD; Kim A. Reiss, MD; Mark E. Robson, MD; Susan M. Domchek, MD : Uptake and acceptability of a mainstreaming model of hereditary cancer multigene panel testing among patients with ovarian, pancreatic, and prostate cancer. Genetics in Medicine July 2021.

W. Tristram Arscott, M.D, Kevin T. Nead, M.D, M.Phil, Adham Bear, M.D., Sriram Venigalla, M.D., Jacob Shabason, M.D., J. Nickolas Lukens, M.D., John P. Plastaras, M.D./Ph.D., Andrzej Wojcieszynski, M.D., James Metz, M.D., Mark O’Hara, M.D., Kim A. Reiss, M.D., Ursina Teitelbaum, M.D., Arturo Loaiza-Bonilla, M.D, Jeffrey Drebin, M.D., Major Kenneth Lee, IV, M.D./Ph.D, Stuti G. Shroff, M.D./Ph.D., Edgar Ben-Josef, M.D.: Concurrent Nab-Paclitaxel and Radiotherapy - Novel Radiosensitization for Borderline Resectable or Unresectable Pancreatic Cancer. American Journal of Clinical Oncology July 2021.

Timothy J Brown, Benjamin Karasic, Charles Schneider, Ursina Teitelbaum, Kim Reiss, Tara Mitchell, Ryan Massa, Mark O'Hara, Lisa DiCicco, Luis Garcia-Marcano, Ravi Amaravadi, Peter O'Dwyer: Phase I Trial of Regorafenib, Hydroxychloroquine and Entinostat in Metastatic Colorectal Cancer. ASCO 2021, Chicago, IL June 2021.

Kim A. Reiss, MD; Rosemarie Mick, MS; Mark H. O’Hara, MD; Ursina Teitelbaum, MD; Thomas B. Karasic, MD; Charles Schneider, MD; Stacy Cowden, RN; Traci Southwell, RN; Janae Romeo, MBE; Natallia Izgur, RN; Zain M. Hannan, BA; Rashmi Tondon, MD; Katharine Nathanson, MD; Robert H. Vonderheide, MD, DPhil; Max M. Wattenberg, MD; Gregory Beatty, MD, PhD; Susan M. Domchek, MD: A Phase II Study of Maintenance Rucaparib in Patients with Platinum Sensitive Advanced Pancreatic Cancer and a Pathogenic Germline or Somatic Variant in BRCA1, BRCA2 or PALB2 Journal of Clinical Oncology May 2021.

Kim A. Reiss and Robert H. Vonderheide: Alternatives to Perpetual Chemotherapy for Metastatic Pancreatic Cancer. Clinical Cancer Research Apr 2021.

Shun Yu, MD; Ronac Mamtani, MD, MSCE1; Mark H. O’Hara, MD; Peter J. O’Dwyer, MD; Ofer Margalit, MD; Bruce J. Giantonio, MD; Einat Shmueli, MD, Kim A. Reiss, MD* and Ben Boursi, MD1* *Authors contributed equally: Comparative effectiveness of total neoadjuvant therapy versus standard adjuvant chemotherapy for locally advanced rectal cancer Clinical Colorectal Cancer Feb 2021.

Ofer Margalit; Einat Shacham-Shmueli; Yu-Xiao Yang; Yaacov R. Lawerence; Kim A. Reiss; Talia Golan; Naama Halpern; Dan Aderka; Bruce Giantonio ; Ronac Mamtani; and Ben Boursi: Prognostic Implications of Tumor Differentiation in Clinical T1N0 Gastric Adenocarcinoma. The Oncologist Jan 2021.

Zain Hannan, BA; Shun Yu, MD; Susan Domchek, MD; Ronac Mamtani, MD; Kim A. Reiss, MD: Clinical Characteristics of Patients with Pancreatic Cancer and Pathogenic ATM Alterations. JNCI Cancer Spectrum Jan 2021.

back to top
Last updated: 09/13/2021
The Trustees of the University of Pennsylvania